In our systematic screening programme for marine actinomycetes, a bioactive streptomycete was isolated from marine sediment samples of the Bay of Bengal, India. The isolate yielded a new cytotoxic compound. This was obtained by solvent extraction followed by chromatographic purification. The pure compound was identified from spectroscopic data as a quinone-related antibiotic, 1-hydroxy-1-norresistomycin (1). It showed a potent cytotoxic activity against cell lines viz. HMO2 (gastric adenocarcinoma) and HePG2 (hepatic carcinoma) in vitro. It also exhibited antibacterial activities against Gram-positive and Gram-negative bacteria.
starch casein agar (composition: soluble starch 1.0%, casein 0.03%, KNO 3 0.2%, NaCl 0.2%, K 2 HPO 4 0.005%, CaCO 3 0.002%, FeSO 4 · 7H 2 O 0.001%, and agar 2.0%) was transferred into Erlenmeyer flasks (2ϫ250 ml) containing 50 ml of seed medium (composition: soyabean meal 1.0%, cornsteep solids 1.0%, glucose 0.5% and CaCO 3 0.5% with pH 7.0) and incubated for 2 days at 28°C on a rotary shaker (220 rpm).This culture was transferred as a 10% (v/v) inoculum into 200 ml aliquots of the production medium contained in 30ϫ1 litre EM flasks. The medium composition was: soyabean meal 1.0%, corn steep solids 0.5%, soluble starch 1.0%, glucose 0.5% and CaCO 3 0.7% with pH 7.0. The inoculated production flasks were incubated for 56 hours at 28°C on a rotary shaker (220 rpm).
The culture broth (6 litres) was centrifuged at 4000 rpm for 10 minutes, at 10°C and clear culture supernatant was separated. It was extracted twice with ethyl acetate (2ϫ1.2 litres) and washed with 500 ml water at pH 7.0. The ethyl acetate layer was concentrated in vacuum at 35°C to give 5.0 g of the crude ethyl acetate extract. A polymer was obtained from the crude ethyl acetate extract, which did not possess any antimicrobial activity. The mycelium was extracted with acetone (1.0 litre) and then centrifuged (4000 rpm, 10 minutes, 10°C). The acetone extract was concentrated in vacuum and lyophilized to obtain 4.5 g of mycelium extract.
The mycelium extract (4.5 g) was chromatographed on a silica gel column (22ϫ5 cm) and eluted with dichloromethane/methanol (95 : 5, 1 litre) to give ten fractions. The dried residues of all 10 fractions were dissolved, each in a specified volume of dichloromethane to give 1 mg/ml concentration and tested for their antimicrobial activities using Bacillus subtilis as test organism by disc-plate method. Among 10 fractions, fraction VI (49.8 mg) exhibited good activity and was purified by chromatography on Sephadex LH-20 (methanol) to obtain four fractions. The third fraction VIc was found to possess good antimicrobial activity while others have no or negligible activites. The active fraction VIc was further purified by chromatography on Sephadex LH-20 (acetone) resulting in two distinct fractions VIc.I (6 mg) and VIc.II (4.5 mg). Fraction VIc.I (1) had good antimicrobial activity (100 m g/ml) but negligible activity was observed with VIc.II. Compound 1 was found to be pure and was pale yellow solid.
The groups in the molecule. In the aromatic region three singlets at dϭ7.48, 7.08 & 6.39 with relative intensity of one proton each were observed. This indicated the presence of three different protons. A broad singlet of one proton intensity appeared at dϭ6.32, this indicates the presence of hydroxyl group attached to alicyclic or cyclic compound. The singlet of three proton intensity peak at d ϭ2.94 indicated the presence of a methyl group either on an aromatic ring or on heteroatom. Another peak at dϭ1.48 with three proton intensity also indicates the presence of another methyl group attached to either a cyclic or an aliphatic moiety. The 13 C-NMR spectrum exhibited two signals at dϭ204.3 & 184.7 and these peaks indicated the presence of two carbonyl groups. In addition to this, 17 signals in the aromatic region and two signals in the aliphatic region were observed. The HMBC and HSQC data of 1 presented in Fig. 2 were crucial in determining the structure and are in full agreement with the structure. The important evidence of the structure comes from the HMBC correlation noticed for C-1 carbon with the protons of the methyl group 12-H 3 (1.48) and the proton at C-11 (7.48). The above spectral data suggest the structure for 1 as shown in Figs.1 and 2 . A comparison of 13 C-NMR data of the pure 1 with that of the reported compound resistomycin [14, 15] was made ( Table  1) . The 13 C-NMR data of the pure 1 is almost similar to resistomycin (2) except at C-1 because of the presence of hydroxyl group.
The spectral information of the 1 was searched in different databases like Chapman and Hall, SciFinder, Beilstein and Antibase and no hints were observed in any of the databases. This indicated that 1-hydroxy-1-norresistomycin (1), {1,3,5,7,10-pentahydroxy-1,9-dimethyl-2H-benzo[cd] pyren-2,6(1H)-dion} is not reported so far (Figs. 1 and 2) and it is the only resistomycin analogue reported to date. The minimum inhibitory concentrations (MIC) of the 1 against different test organisms were determined by the broth dilution method (Table 3) . 
